Cognitive Impact of Pomegranate Polyphenols Following Ischemic Stroke
Status: | Recruiting |
---|---|
Conditions: | Neurology |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 18 - 89 |
Updated: | 4/21/2016 |
Start Date: | June 2015 |
End Date: | July 2016 |
Contact: | Richard Hartman, PhD |
Email: | rhartman@llu.edu |
The Effects of Pomegranate Polyphenols on Neuropsychological Functioning Following Ischemic Stroke
The purpose of this study is to determine whether pomegranate supplements improve cognitive
functioning following stroke.
functioning following stroke.
Research suggests that antioxidants (substances that may slow or prevent cell damage) found
in many fruits and vegetables may help improve brain functioning (for example, memory and
attention) in healthy individuals and prevent cognitive decline in individuals who have
suffered a stroke. The purpose of this research study is to examine whether dietary
supplementation with an antioxidant extract can help promote healthy cognitive functioning
as a component of recovery after stroke. The procedures include: Administering polyphenols
via 2 POMx pills, each of which contains polyphenols derived from pomegranates equivalent to
the content of approximately 8 ounces of pomegranate juice, or placebo pills (capsules
containing no polyphenol ingredients), every day for one week to inpatients who are in the
acute post-stroke phase. Neuropsychological testing pre- and post-treatment will determine
whether cognitive functioning changes. Subjects will be randomized into either a placebo or
polyphenol group.
in many fruits and vegetables may help improve brain functioning (for example, memory and
attention) in healthy individuals and prevent cognitive decline in individuals who have
suffered a stroke. The purpose of this research study is to examine whether dietary
supplementation with an antioxidant extract can help promote healthy cognitive functioning
as a component of recovery after stroke. The procedures include: Administering polyphenols
via 2 POMx pills, each of which contains polyphenols derived from pomegranates equivalent to
the content of approximately 8 ounces of pomegranate juice, or placebo pills (capsules
containing no polyphenol ingredients), every day for one week to inpatients who are in the
acute post-stroke phase. Neuropsychological testing pre- and post-treatment will determine
whether cognitive functioning changes. Subjects will be randomized into either a placebo or
polyphenol group.
Inclusion Criteria:
- Suffered an ischemic stroke and admitted to LLUMC Rehabilitation Institute for
inpatient care
- Fluent in English
- Between the age of 18 and 89 years old
Exclusion Criteria:
- Less than 6 years of education
- Global aphasia
- Pregnant
- History of allergy to pomegranates
- History of traumatic brain injury
- Neurodegenerative disease or neurologic condition with known cognitive impact (e.g.,
Alzheimer's disease)
- Active renal disease
- Active liver disease
- Intracerebral hemorrhage in past 6 months
- Neurosurgery in past month
- Taking warfarin (Coumadin)
We found this trial at
1
site
Click here to add this to my saved trials